Sponsored

The convergence of tech and biology is creating a compelling investment environment for the sector, say Brett Zbar and Mark Stevenson at General Atlantic.

Buoyed by growth trends, buyouts in the lower mid-market offer significant opportunities for value creation, says Vesey Street Capital Partners’ Adam Feinstein.

Providing inclusive and equal opportunities is closely tied to wider social and sustainability issues, all of which hinge on changing behaviours, says Ardian’s head of sustainability, Candice Brenet.

Even amid a wider dealflow drought, Germany’s mid-market is thriving. This comes as a result of relatively low PE penetration, fragmented industries and a new generation of ambitious managers.

Pharma services is creating cross-border opportunities, but GPs should be aware of regulatory and structural issues at play in different jurisdictions, say McDermott Will & Emery’s Kristian Werling and Ellie West.

EY’s Bridget Walsh explains how GPs are refining their value-creation strategies and repositioning themselves towards emerging opportunities in a dislocated market.

Single-asset continuation funds are becoming a disruptive force in the sponsor-to-sponsor M&A market, say Evercore managing director Jim Tilson and vice-president Mike Selverian.

Emerging managers can provide an edge in pursuing niche, overlooked or special strategies, say Adams Street’s Sunil Mishra, Sergey Sheshuryak and James Korczak.

Firms that provide primary fund capital may have a distinct advantage in secondaries investing, say LGT Capital Partners’ Martha Heitmann and Andrew DiGeronimo.

As GP-led secondaries continue to grow in popularity, TPG’s Michael Woolhouse and Matt Jones argue that these are a distinct discipline from their LP counterparts, requiring specialization to flourish.